2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow RA: new trials by email Literature Review of RA trials Research Report on RA
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Auto-injector Real Life Handling in Patients Adalimumab - RA | Phase 3 | Completed | Alvotech Swiss AG | 107 | 2019-11-04 | 2022-05-05 |
| To Evaluate Sarilumab - SAR153191 (REGN88) - Auto-injector Device In Patients With Rheumatoid Arthritis Sarilumab, Auto-Injector Device (AID), Pre-filled Syringe (PFS) - RA | Phase 3 | Completed | Sanofi | 217 | 2014-03-01 | 2017-06-20 |
Adalimumab (1) · Hydroxychloroquine (1) · Leflunomide (1) · Methotrexate (1) · Sulfasalazine (1) · sarilumab (1)
Alvotech Swiss AG (1) · Sanofi (1)
Chile (1) · Georgia (1) · Mexico (1) · Poland (1) · Russia (1) · South Africa (1) · Ukraine (1) · United States (1)